Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Oral rimegepant for migraine prevention

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Edvinsson, Lars. / Oral rimegepant for migraine prevention. I: Lancet. 2021 ; Bind 397, Nr. 10268. s. 4-5.

Bibtex

@article{808dd8dc65b14fae9351cc71cadb7e83,
title = "Oral rimegepant for migraine prevention",
keywords = "Calcitonin Gene-Related Peptide Receptor Antagonists, Double-Blind Method, Humans, Migraine Disorders/prevention & control, Piperidines, Pyridines",
author = "Lars Edvinsson",
year = "2021",
month = jan,
day = "2",
doi = "10.1016/S0140-6736(20)32624-6",
language = "English",
volume = "397",
pages = "4--5",
journal = "The Lancet",
issn = "0140-6736",
publisher = "The/Lancet Publishing Group",
number = "10268",

}

RIS

TY - JOUR

T1 - Oral rimegepant for migraine prevention

AU - Edvinsson, Lars

PY - 2021/1/2

Y1 - 2021/1/2

KW - Calcitonin Gene-Related Peptide Receptor Antagonists

KW - Double-Blind Method

KW - Humans

KW - Migraine Disorders/prevention & control

KW - Piperidines

KW - Pyridines

UR - http://www.scopus.com/inward/record.url?scp=85098652613&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(20)32624-6

DO - 10.1016/S0140-6736(20)32624-6

M3 - Comment/debate

C2 - 33338436

VL - 397

SP - 4

EP - 5

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10268

ER -

ID: 61735799